Head-to-head · WeighScore
AVArx vs RxPepsDirect
The verdict
RxPepsDirect takes it — 68.7/100 to 55.9/100.
RxPepsDirect grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxPepsDirect (Peptide RX LLC) is a per-vial compounded GLP-1 telehealth platform offering semaglutide/B12 from $25/vial and tirzepatide/B12 from $45/vial, dispensed through Optimal Balance Pharmacy (503A,…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AVArx | RxPepsDirect |
|---|---|---|
| WeighScore | 55.9/100 | 68.7/100 |
| Grade | C | C |
| Scorecard rank | #427 | #146 |
| Semaglutide | Not disclosed | $64/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | Not disclosed | $84/mo (starting dose, plus a separate fee, compounded) |
| Coverage | All 50 states | 28 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #427 · C
Strengths
- Publishes exactly which states require a live audio or video visit before a prescription, which almost no competitor discloses
- Names its prescribing group, Arora Health & Aesthetics, and gives a medical compliance contact
- Terms state service is available to residents of all 50 states, and the shipping policy matches
- Dates its own editorial reviews on treatment pages
- HSA/FSA accepted with receipts provided for reimbursement
Where it loses points
- No price is published anywhere on the site, on treatment pages or in the intake, so you cannot compare before starting a visit
- Never states whether its semaglutide and tirzepatide are compounded or brand-name
- No dispensing pharmacy is named, only licensed pharmacies in our network
- Cancellation terms are not published, only presented at checkout
- Prescriptions cannot be returned once dispensed, and the refund policy is otherwise unstated
Graded #146 · C
Strengths
- Industry-lowest GLP-1 pricing: compounded semaglutide from $25/vial, tirzepatide from $45/vial — no subscription or recurring commitment required
- Real 503A telehealth Rx: licensed NP/PA prescribers + MD medical director (Dr. Jonathan Snipes, NPI 1821250077); patient-specific Rx dispensed by
- FedEx overnight shipping at $15 flat; ships pre-reconstituted and includes syringes, alcohol wipes, and reusable cooled travel case
- Independent batch COA testing by Eagle Analytical (FDA-registered, A2LA ISO 17025): 54/54 sterility and endotoxin passes published publicly on
- No subscription required; $39 flat visit fee covers up to 3 peptides per Rx; pay per vial with no ongoing commitment
Where it loses points
- No LegitScript certification; company founded 2026 — no public track record or long-term patient-outcomes data
- Minimal clinical oversight: $39 asynchronous intake form only — no live video consult required, no labs mandated, no monitoring protocol; lowest
- Per-vial pricing makes true monthly cost opaque; every refill costs another $39 visit fee on top of vial price and $15 shipping
- Only 28 states + DC; excludes California, most of the Southeast (AL, AR, GA, MS, NC, SC, TN, VA), and parts of Midwest
- No coaching, labs, dietitian support, or clinical monitoring included at any tier — purely prescription + dispensing
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.